ASTH vs. TER
ASTH (Astrana Health Inc) and TER (Teradyne, Inc.) are both stocks. ASTH operates in Medical Care Facilities (Healthcare), while TER operates in Semiconductor Equipment & Materials (Technology). Over the past 10 years, ASTH returned 20.92%/yr vs 36.21%/yr for TER. At a 0.17 correlation, their price movements are largely independent.
Performance
ASTH vs. TER - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASTH achieves a 47.92% return, which is significantly lower than TER's 111.82% return. Over the past 10 years, ASTH has underperformed TER with an annualized return of 20.92%, while TER has yielded a comparatively higher 36.21% annualized return.
ASTH
- 1D
- -0.57%
- 1M
- 4.92%
- YTD
- 47.92%
- 6M
- 59.43%
- 1Y
- 45.69%
- 3Y*
- 2.84%
- 5Y*
- -0.12%
- 10Y*
- 20.92%
TER
- 1D
- 4.34%
- 1M
- 21.45%
- YTD
- 111.82%
- 6M
- 110.17%
- 1Y
- 404.26%
- 3Y*
- 58.93%
- 5Y*
- 25.97%
- 10Y*
- 36.21%
ASTH vs. TER - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASTH Astrana Health Inc | 47.92% | -21.31% | -17.68% | 29.44% | -59.73% | 302.19% | -0.76% | -7.25% | -17.29% | 220.00% |
TER Teradyne, Inc. | 111.82% | 54.39% | 16.51% | 24.78% | -46.35% | 36.81% | 76.73% | 118.93% | -24.37% | 66.16% |
Correlation
The correlation between ASTH and TER is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Feb 24, 2011 | 0.17 |
The correlation between ASTH and TER shifts across timeframes, from 0.03 (1 year) to 0.31 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
ASTH:
$1.80B
TER:
$64.58B
ASTH:
$0.61
TER:
$5.38
ASTH:
59.95
TER:
76.20
ASTH:
0.51
TER:
17.19
ASTH:
2.25
TER:
20.54
ASTH:
$3.53B
TER:
$3.79B
ASTH:
$238.21M
TER:
$2.23B
ASTH:
$125.28M
TER:
$1.11B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASTH vs. TER — Risk / Return Rank
ASTH
TER
ASTH vs. TER - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Astrana Health Inc (ASTH) and Teradyne, Inc. (TER). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ASTH | TER | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -5.65 | ||
| Sortino ratioReturn per unit of downside risk | -3.57 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.70 | -0.50 |
| Calmar ratioReturn relative to maximum drawdown | 0.99 | 15.25 | -14.26 |
| Martin ratioReturn relative to average drawdown | 2.19 | 55.87 | -53.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ASTH | TER | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.63 | 6.28 | -5.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.00 | 0.53 | -0.53 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.23 | 0.81 | -0.58 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.14 | 0.23 | -0.09 |
Drawdowns
ASTH vs. TER - Drawdown Comparison
The maximum ASTH drawdown since its inception was -84.80%, smaller than the maximum TER drawdown of -97.30%. Use the drawdown chart below to compare losses from any high point for ASTH and TER.
Loading charts...
Drawdown Indicators
| ASTH | TER | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.80% | -97.30% | +12.50% |
Max Drawdown (1Y)Largest decline over 1 year | -46.41% | -26.73% | -19.68% |
Max Drawdown (3Y)Largest decline over 3 years | -70.96% | -58.18% | -12.78% |
Max Drawdown (5Y)Largest decline over 5 years | -84.80% | -59.12% | -25.68% |
Max Drawdown (10Y)Largest decline over 10 years | -84.80% | -59.12% | -25.68% |
Current DrawdownCurrent decline from peak | -69.28% | -1.97% | -67.31% |
Average DrawdownAverage peak-to-trough decline | -47.09% | -58.71% | +11.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.93% | 7.28% | +13.65% |
Volatility
ASTH vs. TER - Volatility Comparison
The current volatility for Astrana Health Inc (ASTH) is 12.20%, while Teradyne, Inc. (TER) has a volatility of 20.31%. This indicates that ASTH experiences smaller price fluctuations and is considered to be less risky than TER based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASTH | TER | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.20% | 20.31% | -8.11% |
Volatility (6M)Calculated over the trailing 6-month period | 49.17% | 50.09% | -0.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.92% | 64.87% | +8.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 65.60% | 49.61% | +15.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 92.46% | 44.96% | +47.50% |
Dividends
ASTH vs. TER - Dividend Comparison
ASTH has not paid dividends to shareholders, while TER's dividend yield for the trailing twelve months is around 0.12%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASTH Astrana Health Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TER Teradyne, Inc. | 0.12% | 0.25% | 0.38% | 0.41% | 0.50% | 0.24% | 0.33% | 0.53% | 1.15% | 0.67% | 0.94% | 1.16% |
Financials
ASTH vs. TER - Financials Comparison
This section allows you to compare key financial metrics between Astrana Health Inc and Teradyne, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ASTH vs. TER - Profitability Comparison
ASTH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Astrana Health Inc reported a gross profit of 0.00 and revenue of 965.10M. Therefore, the gross margin over that period was 0.0%.
TER - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported a gross profit of 780.95M and revenue of 1.28B. Therefore, the gross margin over that period was 60.9%.
ASTH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Astrana Health Inc reported an operating income of 28.53M and revenue of 965.10M, resulting in an operating margin of 3.0%.
TER - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported an operating income of 473.00M and revenue of 1.28B, resulting in an operating margin of 36.9%.
ASTH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Astrana Health Inc reported a net income of 14.44M and revenue of 965.10M, resulting in a net margin of 1.5%.
TER - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Teradyne, Inc. reported a net income of 398.91M and revenue of 1.28B, resulting in a net margin of 31.1%.
Frequently Asked Questions
ASTH and TER have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TER has higher volatility (20.31%) compared to ASTH (12.20%). In terms of maximum drawdown, ASTH dropped -84.80% vs TER's -97.30%.
TER currently has the higher Sharpe Ratio (6.28 vs 0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASTH and TER
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer